Dr. Ngu Lock Hock

Consultant Clinical Geneticist & Paediatrician Clinical Lead in Inherited Metabolic Diseases  Genetics Department, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia

Dr. Ngu Lock Hock, MBBS (Malaysia), MRCP (UK), is a Consultant Clinical Geneticist & Paediatrician and the Clinical Lead in Inherited Metabolic Diseases at the Genetics Department of Hospital Kuala Lumpur, which serves as the national referral centre for inherited metabolic diseases and genetic disorders in Malaysia.

Dr. Ngu is the medical advisor for the Malaysia Lysosomal Diseases Association, a support group for lysosomal disorders. He has published over 50 manuscripts in peer-reviewed journals in the field of genetics and inherited metabolic diseases, including the Journal of Inherited Metabolic Disease and Journal of Medical Genetics. He was invited to speak at over 100 local and international events and has presented over 50 free papers since 2003. He also served as an invited reviewer for international journals such as Molecular Genetics and Metabolism and Clinical Genetics. He is a member of the Ministry of Health Malaysia's Technical Committee on Enzyme Replacement Therapy for Lysosomal Storage Disorders and the Expert Committee on Orphan Drugs, and Asia Pacific MPS Network. He is the principal investigator at Hospital Kuala Lumpur for a number of clinical studies and is the current Chairman of Hospital Kuala Lumpur Research Review Committee.

Dr. Leong Huey Yin

Consultant in Clinical Genetics & Inherited Metabolic Disorders Hospital Kuala Lumpur

Dr. Leong Huey Yin is a Pediatrician in Inherited Metabolic Disease & Clinical Genetics at the Genetics Department in Hospital Kuala Lumpur, Malaysia. This is the national referral center for diagnosis of inherited metabolic diseases. Dr. Leong joined the department since year 2012. She is experienced in diagnosing and treating patients with mucopolysaccharidosis (MPS), in particular with enzyme replacement therapy. Based on her knowledge in this area, Dr. Leong developed the standard operating procedure guidelines for enzyme replacement therapy at her hospital. Dr. Leong obtained her medical degree from the National University of Malaysia in 2003. She became a member of the Royal College of Paediatric and Child Health, United Kingdom in 2009. Following this, she completed a 1-year fellowship in the field of inherited metabolic disease at Sheffield Children’s Hospital, United Kingdom in 2015.

Having a keen interest and knowledge of MPS, Dr. Leong was the principal investigator for the Malaysian Morquio A Program, a national clinical study of patients with MPS IVA. She has published articles in peer reviewed journals and has presented her research at a number of national and international conferences in the field of inherited metabolic diseases.